Search Results - "Beith, J"

ASCT2/SLC1A5 controls glutamine uptake and tumour growth in triple-negative basal-like breast cancer by van Geldermalsen, M, Wang, Q, Nagarajah, R, Marshall, A D, Thoeng, A, Gao, D, Ritchie, W, Feng, Y, Bailey, C G, Deng, N, Harvey, K, Beith, J M, Selinger, C I, O'Toole, S A, Rasko, J E J, Holst, J

“…Alanine, serine, cysteine-preferring transporter 2 (ASCT2; SLC1A5) mediates uptake of glutamine, a conditionally essential amino acid in rapidly proliferating…”
Get full text

Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence by Butow, P., Kelly, S., Thewes, B., Hruby, G., Sharpe, L., Beith, J.

“…Background Fear of cancer recurrence (FCR) is a common and severe problem amongst cancer survivors, but mechanisms to explain its development and maintenance…”
Get full text

Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours by Thewes, B., Butow, P., Bell, M. L., Beith, J., Stuart-Harris, R., Grossi, M., Capp, A., Dalley, D.

“…Purpose Fear of cancer recurrence (FCR) is common and associated with younger age. This study aimed to explore the prevalence and correlates of FCR amongst…”
Get full text

Assessment of Breast Cancer-Related Arm Lymphedema-Comparison of Physical Measurement Methods and Self-Report by Czerniec, S. A., Ward, L. C., Refshauge, K. M., Beith, J., Lee, M. J., York, S., Kilbreath, S. L.

“…ABSTRACT Purpose To determine the relationship between physical methods of measuring lymphedema and self-reported swelling, their reliability, and standard…”
Get full text

Risk factors for lymphoedema in women with breast cancer: A large prospective cohort by Kilbreath, S.L, Refshauge, K.M, Beith, J.M, Ward, L.C, Ung, O.A, Dylke, E.S, French, J.R, Yee, J, Koelmeyer, L, Gaitatzis, K

“…Abstract A prospective study was conducted to identify women at increased risk for lymphoedema (LE) based on axillary surgery. Assessment occurred prior to…”
Get full text

Diagnosis of upper limb lymphedema: development of an evidence-based approach by Dylke, E S, Schembri, G P, Bailey, D L, Bailey, E, Ward, L C, Refshauge, K, Beith, J, Black, D, Kilbreath, S L

“…The diagnosis of secondary upper limb lymphedema (LE) is complicated by the lack of an agreed-upon measurement tool and diagnostic threshold. The aim of this…”
Get more information

Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study by Thewes, B., Bell, M. L., Butow, P., Beith, J., Boyle, F., Friedlander, M., McLachlan, S. A.

“…Background Fear of cancer recurrence (FCR) is a common problem amongst survivors. Past research has shown that young women with breast cancer are particularly…”
Get full text

De novo and recurrent metastatic breast cancer – A systematic review of population-level changes in survival since 1995 by Lord, SJ, Bahlmann, K, O'Connell, DL, Kiely, BE, Daniels, B, Pearson, SA, Beith, J, Bulsara, MK, Houssami, N

“…Advances in breast cancer (BC) care have reduced mortality, but their impact on survival once diagnosed with metastasis is less well described. This systematic…”
Get full text

Psychological intervention (ConquerFear) for treating fear of cancer recurrence: mediators and moderators of treatment efficacy by Sharpe, Louise, Turner, J., Fardell, J. E., Thewes, B., Smith, A. B., Gilchrist, J., Beith, J., Girgis, A., Tesson, S., Day, S., Grunewald, K., Butow, P.

“…Purpose ConquerFear is an efficacious intervention for fear of cancer recurrence (FCR) that demonstrated greater improvements than an attention control…”
Get full text

Recurring photic zone euxinia in the northwest Tethys impinged end-Triassic extinction recovery by Beith, Sarah J., Fox, Calum P., Marshall, John E.A., Whiteside, Jessica H.

“…The end-Triassic extinction (ETE) is associated with rapid atmospheric CO2-driven warming amplified by positive feedbacks involving weathering, nutrient…”
Get full text

Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study by Oh, B, Kimble, B, Costa, D S J, Davis, E, McLean, A, Orme, K, Beith, J

“…Background Aromatase inhibitors (AIs) are recommended as adjuvant hormone treatment for postmenopausal women with early breast cancer. A substantial proportion…”
Get full text

Quality of life of women treated with radiotherapy for breast cancer by Lee, T. S., Kilbreath, S. L., Refshauge, K. M., Pendlebury, S. C., Beith, J. M., Lee, M. J.

“…Goals of work Radiotherapy is routinely used in the treatment of early breast cancer, particularly in women who have undergone lumpectomy. Its impact on the…”
Get full text

Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now? by Duric, V. M., Stockler, M. R., Heritier, S., Boyle, F., Beith, J., Sullivan, A., Wilcken, N., Coates, A. S., Simes, R. J.

“…Background: Studies of women who had adjuvant chemotherapy for early breast cancer 10–20 years ago showed that many judged small benefits sufficient to make it…”
Get full text

Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse by Lomax, A. J., Beith, J., Bhadri, V., Boyer, M., Grimison, P., Horvath, L. G., Kao, S., Tattersall, M., Thomas, D., McNeil, C.

“…Background Immunotherapy agents show anti‐cancer activity in several solid cancers. Efficacy in non‐melanoma solid tumours for non‐approved indications is…”
Get full text

Pectoral stretching program for women undergoing radiotherapy for breast cancer by LEE, T. S, KILBREATH, S. L, REFSHAUGE, K. M, PENDLEBURY, S. C, BEITH, J. M, LEE, M. J

“…Surgery and radiotherapy commonly cause adverse musculoskeletal problems, particularly loss of strength and range of motion, in the upper quadrant of breast…”
Get full text

O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatrib by Watson, A J, Middleton, M R, McGown, G, Thorncroft, M, Ranson, M, Hersey, P, McArthur, G, Davis, I D, Thomson, D, Beith, J, Haydon, A, Kefford, R, Lorigan, P, Mortimer, P, Sabharwal, A, Hayward, O, Margison, G P

“…We evaluated the pharmacodynamic effects of the O(6)-methylguanine-DNA methyltransferase (MGMT) inactivator lomeguatrib (LM) on patients with melanoma in two…”
Get full text

3619 POSTER Factors Affecting Time From Surgery to Adjuvant Chemotherapy for Early Breast Cancer in a Rural and Urban Medical Oncology Unit – a Retrospective Cohort Study by Fox, P.N, Chatfield, M.D, Beith, J, Turley, K, Grimison, P.S

Get full text

Unusual metastases from lobular carcinoma of the breast by Venkateswaran, R., Beith, J. M.

Get full text

A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma by Kefford, R F, Thomas, N P B, Corrie, P G, Palmer, C, Abdi, E, Kotasek, D, Beith, J, Ranson, M, Mortimer, P, Watson, A J, Margison, G P, Middleton, M R

“…Lomeguatrib, an O 6 -methylguanine-DNA methyltransferase inactivator, was evaluated in an extended dosing regimen with temozolomide, designed according to…”
Get full text

354 Assessment of an algorithm for prevention of aromatase inhibitor-associated bone loss: two year results by White, K.L, Yeow, E, Beith, J, Lee, C.P, Broad, A, Sewak, S, Abdi, E, Sambrook, P.N, Bell, R

Get full text